Institut Catala d'Oncologia

Badalona 8916

1 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia, Chronic Graft-versus-host Disease, Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS), Myelodysplastic Syndromes (MDS)

Studies at this site

• Ivosidenib (IVO) Monotherapy and Azacitidine (AZA) Monotherapy in Patients With Hypomethylating Agent (HMA) Naive Myelodysplastic Syndromes (MDS) With an IDH1 Mutation — Recruiting now
• GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Stopped early
• Alvocidib Biomarker-driven Phase 2 AML Study — Stopped early